PPMD announced today that they will award Dr. M. Carrie Miceli and her team at UCLA’s David Geffen School of Medicine and College of Letters and Science, a $50,000 exploratory grant to continue their evaluation of exon skipping boosters for the treatment of Duchenne. 

Duchenne muscular dystrophy is the most common fatal genetic disorder diagnosed in…

We're excited to announce that John Porter, PhD, former program director of the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) will take on the role of Chief Executive Officer for Parent Project Muscular Dystrophy.

As program director at the NIH/NINDS, Dr. Porter was…

Dr. Subha Raman confers with colleagues in a laboratory at The Ohio State University Wexner Medical Center. Raman published a study that shows a combination of well-established heart medications can dramatically slow the rate of heart damage in patients with Duchenne muscular dystrophy. …